Acorai

Acorai is a Helsingborg-based MedTech startup developing a non-invasive intracardiac pressure monitoring device for heart failure management. The company's sensor technology combines seismic, acoustic, visual, and ECG inputs with machine learning to estimate cardiac pressures without invasive procedures, enabling personalized treatment and reducing hospitalizations. Acorai received a €2.3 million EIC Accelerator grant with a €10 million follow-on offer from the European Innovation Council in early 2025, on top of a $4.5 million seed round in late 2024.